What Has Been The Evolution of the Blood Preparation Market in Recent Years?
The blood preparation market has seen considerable growth due to a variety of factors.
•The market size for blood preparation has seen robust growth lately. It is projected to increase from $48.03 billion in 2024 to $51.28 billion in 2025, representing a compound annual growth rate (CAGR) of 6.7%.
This growth during the historic period is linked to an increase in blood transfusion procedures, a rising incidence of blood disorders, heightened awareness about blood safety, worldwide blood donation efforts, and governmental regulations and standards.
What Is the Forecasted Market Size and Growth Rate for The Blood Preparation Market?
The blood preparation market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of blood preparation is predicted to experience significant expansion in the coming years, growing to a staggering $66.59 billion by 2029 with a compound annual growth rate (CAGR) of 6.8%.
This projected growth during the forecast period is primarily influenced by an increase in the demand for blood components, personalized medicine schemes, the advent of new therapies and applications, and improvements in global health care infrastructure. Automation and integration of blood processing systems, increased demand for pathogen-less blood components, individualized adjustments in blood components, a focus on platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), and stringent regulatory compliance and quality criteria, are among the key trends expected over the forecast period.
What Factors Are Driving Growth In The Blood Preparation Market?
The surge in global blood donations is anticipated to stimulate the expansion of the blood preparation market. Blood donation entails donating blood to aid in the preservation of other lives. This procedure allows for blood transfusions, which are vital for life preservation and support. Patients rely on blood for survival during surgeries, cancer therapies, chronic ailments, and severe injuries. During the blood preparation procedure, it enables transfusions, guaranteeing blood availability whenever and wherever needed. For example, Red Cross Blood, an American biotechnology research firm, projected that around 6.8 million individuals would donate blood in 2023, with approximately 13.6 million units of whole blood and red blood cells collected each year. Consequently, the upsurge in blood donations is facilitating the growth of the blood preparation market.
What Are The Main Segments Of The Global Blood Preparation Market?
The blood preparation market covered in this report is segmented –
1) By Product: Whole Blood, Blood Components, Blood Derivatives
2) By Antithrombotic And Anticoagulants Type: Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants
3) By Application: Transfusion, Diagnostics, Research
4) By End User: Hospitals, Clinics, Blood Banks, Other End-Users
Subsegments:
1) By Whole Blood: Fresh Whole Blood, Stored Whole Blood
2) By Blood Components: Red Blood Cells (RBC), Platelets, Plasma, White Blood Cells (WBC)
3) By Blood Derivatives: Immunoglobulins, Coagulation Factors, Albumin, Fibrinogen
Pre-Book The Blood Preparation Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Blood Preparation Market?
In the blood preparation market, technological advancements are becoming a prominent trend. Companies at the forefront of this market are looking to introduce innovative technological solutions to maintain their market standing. For example, in June 2024, Innobiochips, a biotech company based in France, introduced Omnys, a sophisticated blood grouping and testing solution designed to significantly enhance the accuracy and efficiency of blood transfusion procedures. By utilizing proprietary multiplex technologies, it facilitates advanced testing of blood components like ABO/D typing, phenotyping, extended phenotyping, and antibody screening. The complete system, that includes testing devices, reagents, and consumables, simplifies workflows, enabling medical facilities and labs to conduct precise blood studies with a reduced sample volume.
Who Are the Key Players in the Blood Preparation Market?
Major companies operating in the blood preparation market include:
• AstraZeneca PLC
• Sanofi
• LEO Pharma A/S
• Bristol-Myers Squibb Company
• Baxter International Inc
• Pfizer Inc
• Portola Pharmaceuticals Inc
• GlaxoSmithKline PLC
• Bayer AG
• Boehringer Ingelheim
• Celgene Corp
• Shandong East Chemical Industry Co.
• Xiamen Hisunny Chemical Co. LTD
• Merck & Co.
• Amgen Inc.
• Takeda Pharmaceutical Company Limited
• Novartis AG
• Johnson & Johnson
• Gilead Sciences Inc.
• Regeneron Pharmaceuticals Inc.
• AbbVie Inc.
• Roche Holding AG
• CSL Behring
• BioMarin Pharmaceutical Inc.
• Genentech Inc.
• Sandoz International GmbH
• Medtronic plc
• Fresenius Kabi AG
• Grifols S.A.
• HemaCare Corporation
• Terumo Corporation
What Is The Most Dominant Region In The Blood Preparation Market?
North America was the largest region in the blood preparation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global blood preparation market during the forecast period. The regions covered in the blood preparation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
